![Pei Lan Chu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pei Lan Chu
Direttore Finanziario/CFO presso
SYNERGY SCIENTECH CORP.
Profilo
Pei Lan Chu is currently the Chief Financial Officer & Deputy General Manager at SYNergy ScienTech Corp.
Prior to this, he worked as the Investment Relations Officer at Tanvex BioPharma, Inc. from 2015 to 2019.
Before that, he was the Director-Biotech Section at President International Development Corp.
Mr. Chu holds an MBA from National Sun Yat-Sen University.
Posizioni attive di Pei Lan Chu
| Società | Posizione | Inizio |
|---|---|---|
| SYNERGY SCIENTECH CORP. | Direttore Finanziario/CFO | 01/07/2019 |
Precedenti posizioni note di Pei Lan Chu
| Società | Posizione | Fine |
|---|---|---|
| TANVEX BIOPHARMA, INC. | Contatto Relazioni con gli Investitori | - |
President International Development Corp.
 President International Development Corp. Financial ConglomeratesFinance manages investments and provides financial consulting services | Corporate Officer/Principal | - |
Formazione di Pei Lan Chu
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
25
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
National Sun Yat-Sen University
 National Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SYNergy ScienTech Corp.
 SYNergy ScienTech Corp. Electrical ProductsProducer Manufacturing Manufactures rechargeable lithium-ion and lithium-ion polymer batteries | Producer Manufacturing |
President International Development Corp.
President International Development Corp. Financial ConglomeratesFinance manages investments and provides financial consulting services | Finance |
Tanvex BioPharma, Inc.
 Tanvex BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biosimilar medicines to treat neutropenia, breast cancer and metastatic colorectal cancer | Health Technology |
